Stockscreener 앱 받기
2.99
8.73%
0.24
시간 외 거래:
2.95
-0.04
-1.34%
전일 마감가:
$2.75
열려 있는:
$2.77
하루 거래량:
699.06K
Relative Volume:
1.06
시가총액:
$189.05M
수익:
$4.39M
순이익/손실:
$-22.40M
주가수익비율:
-5.865
EPS:
-0.5098
순현금흐름:
$-22.79M
1주 성능:
+11.99%
1개월 성능:
+37.16%
6개월 성능:
+171.82%
1년 성능:
+806.06%
1일 변동 폭
$2.70
$3.0881
1주일 범위
$2.62
$3.0881
52주 변동 폭
$0.27
$3.45
Equillium Inc Stock (EQ) Company Profile
명칭
Equillium Inc
전화
(858) 412-5302
주소
2223 AVENIDA DE LA PLAYA, LA JOLLA, CA
Compare EQ vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EQ
Equillium Inc
|
2.99 | 177.03M | 4.39M | -22.40M | -22.79M | -0.5098 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Equillium Inc Stock (EQ) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-23 | 개시 | Oppenheimer | Outperform |
| 2026-04-16 | 개시 | B. Riley Securities | Buy |
| 2026-04-14 | 개시 | Raymond James | Strong Buy |
| 2026-04-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2026-03-13 | 개시 | Roth Capital | Buy |
| 2026-02-25 | 개시 | Stifel | Buy |
| 2025-03-28 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2021-10-29 | 재개 | Stifel | Buy |
| 2021-09-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-07-14 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-10 | 재개 | Stifel | Buy |
| 2019-02-22 | 개시 | SVB Leerink | Outperform |
모두보기
Equillium Inc 주식(EQ)의 최신 뉴스
Equillium Inc. (EQ) Holds Steady at $2.81 – Key Support and Resistance Levels in FocusSystematic Flow - newsline.com
Analysts Grow More Confident In Equillium’s (EQ) Lead Asset EQ504 - Insider Monkey
EQ Q1 2026 Earnings: Wider-than-Expected Loss Weighs on SharesRevenue Miss Report - newsline.com
Equillium COO Christine Zedelmayer sells $42,736 in stock - Investing.com UK
Insider Sell: Stephen Connelly Sells 230,975 Shares of Equillium Inc (EQ) - GuruFocus
Equillium COO Christine Zedelmayer sells $42,736 in stock By Investing.com - Investing.com Nigeria
Equillium (NASDAQ: EQ) Form 144: insider resale activity, 200,000-share sale noted - Stock Titan
Equillium Insider Sold Shares Worth $723,830, According to a Recent SEC Filing - marketscreener.com
Equillium (EQ) COO sells 14,584 shares after exercising stock options - Stock Titan
Equillium (NASDAQ: EQ) CSO Stephen Connelly sells 230,975 shares in open market - Stock Titan
[144] Equillium, Inc. SEC Filing - Stock Titan
Equillium, Inc. (EQ) Discusses Mechanistic Insights Linking AhR Signaling and miR-124 in Inflammatory DiseaseSlideshow (NASDAQ:EQ) 2026-06-03 - Seeking Alpha
Equillium(EQ) Stock Options Chain | Quotes & News - Moomoo
Equillium Reports Inducement Grants under Nasdaq Listing Rule 5635(4) - marketscreener.com
EQ Reiterated by Roth Capital -- Price Target Maintained at $12 - GuruFocus
B. Riley Securities Maintains Equillium(EQ.US) With Buy Rating, Maintains Target Price $6 - Moomoo
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Equillium links AhR activation to miR-124 as EQ504 heads toward Phase 1 - MSN
Is Equillium's AhR/miR-124 Axis the Key to Unlocking Inflammatory Disease Treatment - Kavout
Equillium Insider Sold Shares Worth $267,209, According to a Recent SEC Filing - Moomoo
Leerink Partners upgrades Equillium (EQ) - MSN
Equillium principal accounting officer Tom Penny sells $191,750 in stock By Investing.com - Investing.com Nigeria
Equillium sr. vp and coo Christine Zedelmayer sells $267,209 in shares - Investing.com Nigeria
Equillium principal accounting officer Tom Penny sells $191,750 in stock - Investing.com
Equillium sr. vp and coo Christine Zedelmayer sells $267,209 in shares By Investing.com - Investing.com South Africa
Equillium (EQ) accounting officer sells 65,000 shares under 10b5-1 plan - Stock Titan
Equillium (EQ) director receives 70,000 options at $2.84 exercise price - Stock Titan
Equillium (EQ) director receives grant of 70,000 stock options at $2.84 - Stock Titan
[Form 4] Equillium, Inc. Insider Trading Activity - Stock Titan
Equillium (EQ) COO exercises options and sells 95,833 common shares - Stock Titan
Equillium (EQ) grants director 70,000 options vesting over a year - Stock Titan
Equillium (EQ) director Barbara Troupin receives grant of 70,000 stock options - Stock Titan
Equillium Shareholders Approve Reverse Split and Capital Changes - TipRanks
[8-K] Equillium, Inc. Reports Material Event - Stock Titan
Equillium Links AhR Activation to miR-124 as EQ504 Heads Toward Phase 1 - Barchart.com
A Quick Look at Today's Ratings for Equillium(EQ.US), With a Forecast Between $5 to $12 - Moomoo
Leerink upgrades Equillium stock rating on IBD drug potential - Investing.com UK
Equillium Inc. (EQ) Surges 7.98%: Analyzing the Move and Key Technical LevelsAD Line Divergence - The Legal Advocate
EQ Upgraded by Leerink Partners -- Price Target Raised to $6.00 - GuruFocus
Equillium to Participate in the 2026 Jefferies Global Healthcare Conference - GlobeNewswire
Equillium Raised to Outperform From Market Perform by Leerink Partners - Moomoo
Stifel reiterates Equillium stock rating on AhR biology data - Investing.com UK
Equillium (EQ) Upgraded to Outperform with Target Price Raised t - GuruFocus
Stifel reiterates Equillium stock rating on AhR biology data By Investing.com - Investing.com Nigeria
Equillium Inc (EQ) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Equillium Inc 주식 (EQ) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Zedelmayer Christine | Sr. Vice President and COO |
Jun 05 '26 |
Option Exercise |
0.79 |
14,584 |
11,448 |
77,170 |
| Zedelmayer Christine | Sr. Vice President and COO |
Jun 05 '26 |
Sale |
2.93 |
14,584 |
42,737 |
62,586 |
| Connelly Stephen | President and CSO |
Jun 04 '26 |
Sale |
3.16 |
200,000 |
632,760 |
793,000 |
| Connelly Stephen | President and CSO |
Jun 05 '26 |
Sale |
2.94 |
30,975 |
91,070 |
762,025 |
2.60%
0.94%
자본화:
|
볼륨(24시간):